This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2004-2018.
Location History:
- Hainsport, NJ (US) (2010)
- Hainesport, NJ (US) (2004 - 2018)
Company Filing History:
Years Active: 2004-2018
Title: The Innovative Contributions of Robert J Schmidt
Introduction
Robert J Schmidt is a notable inventor based in Hainesport, NJ, who has made significant contributions to the field of cancer treatment through his innovative patents. With a total of five patents to his name, Schmidt has focused on developing anti-mitotic agents and kinase inhibitors that hold promise for cancer therapies.
Latest Patents
Among his latest patents, Schmidt has developed "Tubulysin analogs and methods of making and use." These analogs are designed as anti-mitotic agents that can be utilized in cancer treatment, particularly when conjugated to a targeting moiety. Another significant patent is for "Monocyclic heterocycles as kinase inhibitors," which outlines compounds and methods for their use in treating cancer.
Career Highlights
Schmidt is currently associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm known for its commitment to discovering and developing innovative medicines. His work at the company has allowed him to contribute to groundbreaking research in oncology.
Collaborations
Throughout his career, Schmidt has collaborated with esteemed colleagues, including Robert Michael Borzilleri and Gretchen M Schroeder. These partnerships have further enhanced the impact of his research and innovations in the field.
Conclusion
Robert J Schmidt's contributions to cancer treatment through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in cancer therapies.